{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:32:07Z","timestamp":1771911127677,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s11060-022-03998-6","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T16:17:26Z","timestamp":1649521046000},"page":"551-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study"],"prefix":"10.1007","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8469-7567","authenticated-orcid":false,"given":"F.","family":"Mo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Meletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Belcastro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Quadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Dainese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Scarpelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Florindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mascia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pauletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pellerino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Polosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Conti Nibali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pisanello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Cavallieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rud\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"key":"3998_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","volume":"6","author":"MSM Van Breemen","year":"2007","unstructured":"Van Breemen MSM, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421\u2013430. https:\/\/doi.org\/10.1016\/S1474-4422(07)70103-5","journal-title":"Lancet Neurol"},{"issue":"7","key":"3998_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1634\/theoncologist.2014-0060","volume":"19","author":"CJ Vecht","year":"2014","unstructured":"Vecht CJ, Kerkhof M, Duran-Pena A (2014) Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist 19(7):751\u2013759. https:\/\/doi.org\/10.1634\/theoncologist.2014-0060","journal-title":"Oncologist"},{"issue":"Suppl 4","key":"3998_CR3","doi-asserted-by":"publisher","first-page":"iv55","DOI":"10.1093\/neuonc\/nos199","volume":"14","author":"R Rud\u00e0","year":"2012","unstructured":"Rud\u00e0 R, Bello L, Duffau H, Soffietti R (2012) Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol 14(Suppl 4):iv55\u2013iv64. https:\/\/doi.org\/10.1093\/neuonc\/nos199","journal-title":"Neuro Oncol"},{"issue":"5","key":"3998_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/nop\/npab030","volume":"8","author":"ME De Bruin","year":"2021","unstructured":"De Bruin ME, van der Meer PB, Dirven L, Taphoom MJB, Koekkoek JAF (2021) Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review. Neurooncol Pract 8(5):501\u2013517. https:\/\/doi.org\/10.1093\/nop\/npab030","journal-title":"Neurooncol Pract"},{"issue":"Suppl 9","key":"3998_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/epi.12452","volume":"54","author":"E Perucca","year":"2013","unstructured":"Perucca E (2013) Optimizing antiepileptic drug treatment in tumoral epilepsy. Epilepsia 54(Suppl 9):97\u2013104. https:\/\/doi.org\/10.1111\/epi.12452","journal-title":"Epilepsia"},{"key":"3998_CR6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/tcrm.s5189","volume":"5","author":"C Kellinghaus","year":"2009","unstructured":"Kellinghaus C (2009) Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety. Ther Clin Risk Manag 5:757\u2013766. https:\/\/doi.org\/10.2147\/tcrm.s5189","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"3998_CR7","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3171\/2013.1.JNS12397","volume":"118","author":"MG Saria","year":"2013","unstructured":"Saria MG, Corle C, Hu J, Rudnick JD, Phuphanich S, Mrugala MM, Crew LK, Bota DA, Dan FuB, Kim RY, Brown T, Feely H, Brechlin J, Brown BD, Drappatz J, Wen PY, Chen CC, Carter B, Lee JW, Kesari S (2013) Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article. J Neurosurg 118(6):1183\u20131187. https:\/\/doi.org\/10.3171\/2013.1.JNS12397","journal-title":"J Neurosurg"},{"key":"3998_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.yebeh.2016.09.033","volume":"65","author":"V Villanueva","year":"2016","unstructured":"Villanueva V, Saiz-Diaz R, Toledo M, Piera A, Mauri JA, Rodriguez-Uranga JJ, L\u00f3pez-Gonz\u00e1lez FJ, G\u00f3mez-Ib\u00e1\u00f1ez A, Garc\u00e9s M, Gonz\u00e1lez de la Aleja J, Rodr\u00edguez-Osorio X, Palao-Duarte S, Castillo A, Bonet M, Ruiz-Gim\u00e9nez J, Palau J, Arcediano A, Toledo M, Gago A (2016) NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy. Epilepsy Behav. 65:25\u201332. https:\/\/doi.org\/10.1016\/j.yebeh.2016.09.033","journal-title":"Epilepsy Behav."},{"key":"3998_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.yebeh.2017.05.031","volume":"73","author":"M Maschio","year":"2017","unstructured":"Maschio M, Zarabla A, Maialetti A, Fabi A, Vidiri A, Villani V, Giannarelli D (2017) Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: a prospective explorative study with a historical control group. Epilepsy Behav 73:83\u201389. https:\/\/doi.org\/10.1016\/j.yebeh.2017.05.031","journal-title":"Epilepsy Behav"},{"issue":"1","key":"3998_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11060-017-2628-0","volume":"136","author":"R Rud\u00e0","year":"2018","unstructured":"Rud\u00e0 R, Pellerino A, Franchino F, Bertolotti C, Bruno F, Mo F, Migliore E, Ciccone G, Soffietti R (2018) Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study. J Neurooncol 136(1):105\u2013114. https:\/\/doi.org\/10.1007\/s11060-017-2628-0","journal-title":"J Neurooncol"},{"issue":"4","key":"3998_CR11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/epi.16486","volume":"61","author":"R Rud\u00e0","year":"2020","unstructured":"Rud\u00e0 R, Houillier C, Maschio M, Reijneveld JC, Hellot S, De Backer M, Chan J, Joeres L, Leunikava I, Glas M, Grant R (2020) Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES). Epilepsia 61(4):647\u2013656. https:\/\/doi.org\/10.1111\/epi.16486","journal-title":"Epilepsia"},{"issue":"6","key":"3998_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"issue":"4","key":"3998_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Mosh\u00e9 SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM (2017) ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia 58(4):512\u2013521. https:\/\/doi.org\/10.1111\/epi.13709","journal-title":"Epilepsia"},{"issue":"1","key":"3998_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11060-021-03800-z","volume":"154","author":"MP Van Opijen","year":"2021","unstructured":"Van Opijen MP, van der Meer PB, Dirven L, Fiocco M, Kouwenhoven MCM, van den Bent MJ, Taphoorn MJB, Koekkoek JAF (2021) The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide. J Neurooncol 154(1):73\u201381. https:\/\/doi.org\/10.1007\/s11060-021-03800-z","journal-title":"J Neurooncol"},{"key":"3998_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11060-010-0460-x","volume":"104","author":"M Maschio","year":"2011","unstructured":"Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A, Muti P (2011) Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life. J Neurooncol 104:205\u2013214. https:\/\/doi.org\/10.1007\/s11060-010-0460-x","journal-title":"J Neurooncol"},{"issue":"3","key":"3998_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneurol.2009.335","volume":"67","author":"A Rosati","year":"2010","unstructured":"Rosati A, Buttolo L, Stefini R, Todeschini A, Cenzato M, Padovani A (2010) Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study. Arch Neurol 67(3):343\u2013346. https:\/\/doi.org\/10.1001\/archneurol.2009.335","journal-title":"Arch Neurol"},{"key":"3998_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/s1059-1311(03)00096-7","volume":"12","author":"GL Wagner","year":"2003","unstructured":"Wagner GL, Wilms EB, Van Donselaar CA, Vecht ChJ (2003) Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 12:585\u2013586. https:\/\/doi.org\/10.1016\/s1059-1311(03)00096-7","journal-title":"Seizure"},{"key":"3998_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11060-008-9781-4","volume":"93","author":"DA Lim","year":"2009","unstructured":"Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, Chang S, Lamborn KR, McDermott MW (2009) Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol 93:349\u2013354. https:\/\/doi.org\/10.1007\/s11060-008-9781-4","journal-title":"J Neurooncol"},{"key":"3998_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11060-005-9070-4","volume":"78","author":"HB Newton","year":"2006","unstructured":"Newton HB, Goldlust SA, Pearl D (2006) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78:99\u2013102. https:\/\/doi.org\/10.1007\/s11060-005-9070-4","journal-title":"J Neurooncol"},{"key":"3998_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s11060-017-2473-1","volume":"133","author":"C Vecht","year":"2017","unstructured":"Vecht C, Duran-Pe\u00f1a A, Houillier C, Durand T, Capelle L, Huberfeld G (2017) Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations. J Neurooncol 133:603\u2013607. https:\/\/doi.org\/10.1007\/s11060-017-2473-1","journal-title":"J Neurooncol"},{"key":"3998_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/neuonc\/not057","volume":"15","author":"M Kerkhof","year":"2013","unstructured":"Kerkhof M, Dielemans JC, van Breemen MS, Zwinkels H, Walchenbach R, Taphoorn MJ, Vecht CJ (2013) Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro Oncol 15:961\u2013967. https:\/\/doi.org\/10.1093\/neuonc\/not057","journal-title":"Neuro Oncol"},{"key":"3998_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1634\/theoncologist.2014-0060","volume":"19","author":"CJ Vecht","year":"2014","unstructured":"Vecht CJ, Kerkhof M, Duran-Pena A (2014) Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist 19:751\u2013759. https:\/\/doi.org\/10.1634\/theoncologist.2014-0060","journal-title":"Oncologist"},{"key":"3998_CR23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11060-011-0689-z","volume":"106","author":"M Maschio","year":"2012","unstructured":"Maschio M, Dinapoli L, Sperati F, Fabi A, Pace A, Vidiri A, Muti P (2012) Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life. J Neurooncol 106:651\u2013656. https:\/\/doi.org\/10.1007\/s11060-011-0689-z","journal-title":"J Neurooncol"},{"key":"3998_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11060-006-9229-7","volume":"81","author":"AM Mauro","year":"2007","unstructured":"Mauro AM, Bomprezzi C, Morresi S, Provinciali L, Formica F, Iacoangeli M, Scerrati M (2007) Prevention of early postoperative seizures in patients with primary brain tumors: Preliminary experience with oxcarbazepine. J Neurooncol 81:279\u2013285. https:\/\/doi.org\/10.1007\/s11060-006-9229-7","journal-title":"J Neurooncol"},{"key":"3998_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11060-007-9430-3","volume":"86","author":"M Maschio","year":"2008","unstructured":"Maschio M, Dinapoli L, Zarabla A, Pompili A, Carapella CM, Pace A, Giannarelli D, Occhipinti E, Jandolo B (2008) Outcome and tolerability of topiramate in brain tumor associated epilepsy. J Neurooncol 86:61\u201370. https:\/\/doi.org\/10.1007\/s11060-007-9430-3","journal-title":"J Neurooncol"},{"key":"3998_CR26","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00415-009-5156-9","volume":"256","author":"MSM van Breemen","year":"2009","unstructured":"van Breemen MSM, Rijsman RM, Taphoorn JB, Walchenbach R, Zwinkels H, Vecht CJ (2009) Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 256:1519\u20131526. https:\/\/doi.org\/10.1007\/s00415-009-5156-9","journal-title":"J Neurol"},{"key":"3998_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/epi.13961","volume":"59","author":"AM Faramand","year":"2018","unstructured":"Faramand AM, Barnes N, Harrison S, Gunny R, Jacques T, Tahir MZ, Varadkar SM, Cross HJ, Harkness W, Tisdall MM (2018) Seizure and cognitive outcomes after resection of glioneuronal tumors in children. Epilepsia 59:170\u2013178. https:\/\/doi.org\/10.1111\/epi.13961","journal-title":"Epilepsia"},{"key":"3998_CR28","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1227\/NEU.0b013e3182500a4c","volume":"70","author":"DG Southwell","year":"2012","unstructured":"Southwell DG, Garcia PA, Berger MS, Barbaro NM, Changet EF (2012) Long-term seizure control outcomes after resection of gangliogliomas. Neurosurgery 70:1406\u20131413. https:\/\/doi.org\/10.1227\/NEU.0b013e3182500a4c (discussion 1413\u20131414)","journal-title":"Neurosurgery"},{"key":"3998_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10143-019-01085-5","volume":"43","author":"L Xiangrong","year":"2020","unstructured":"Xiangrong L, Chengjun W, Zhiqin L, Meng Z, Xiaohui R, Xiaohui Z et al (2020) Risk factors and control of seizures in 778 Chinese patients undergoing initial resection of supratentorial meningiomas. Neurosurg Rev 43:597\u2013608. https:\/\/doi.org\/10.1007\/s10143-019-01085-5","journal-title":"Neurosurg Rev"},{"key":"3998_CR30","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s00415-018-8857-0","volume":"265","author":"SG Berntsson","year":"2018","unstructured":"Berntsson SG, Merrell RT, Amirian ES, Armstrong GN, Lachance D, Smits A, Jiang Z (2018) Glioma-related seizures in relation to histopathological subtypes: a report from the glioma international case\u2013control study. J Neurol 265:1432\u20131442. https:\/\/doi.org\/10.1007\/s00415-018-8857-0","journal-title":"J Neurol"},{"key":"3998_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3171\/JNS\/2008\/108\/2\/0227","volume":"108","author":"EF Chang","year":"2008","unstructured":"Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, Berger MS (2008) Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227\u2013235. https:\/\/doi.org\/10.3171\/JNS\/2008\/108\/2\/0227","journal-title":"J Neurosurg"},{"key":"3998_CR32","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3171\/2009.2.JNS081132","volume":"111","author":"KL Chaichana","year":"2009","unstructured":"Chaichana KL, Parker SL, Olivi A, Qui\u00f1ones-Hinojosa A (2009) Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. J Neurosurg 111:282\u2013292. https:\/\/doi.org\/10.3171\/2009.2.JNS081132","journal-title":"J Neurosurg"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-03998-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-022-03998-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-03998-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T07:10:39Z","timestamp":1651734639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-022-03998-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["3998"],"URL":"https:\/\/doi.org\/10.1007\/s11060-022-03998-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"21 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mo F., Meletti S., Belcastro V., Quadri S., Napolitano M., Bello L., Dainese F., Scarpelli M., Florindo I., Mascia A., Pauletto G., Bruno F., Pellerino A., Giovannini G., Polosa M., Sessa M., Conti Nibali M., Gigli G.L., Pisanello A., Cavallieri F.: did not declare conflicts of interests. Di Gennaro G. joined advisory boards and pharmaceutical industry-sponsored symposia for EISAI, UCB, LivaNova, Arvelle. Rud\u00e0 R. joined Advisory Boards and received grants from UCB, Mundipharma, Novocure and Bayer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}